Open AccessFluoroquinolone-resistant Pseudomonas aeruginosa: risk factors for acquisition and impact on outcomes
Author(s) -
Donald Hsu,
Mark P. Okamoto,
Rekha Murthy,
Annie WongBeringer
Publication year - 2005
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dki026
Subject(s) - medicine , pseudomonas aeruginosa , regimen , diabetes mellitus , risk factor , biology , endocrinology , bacteria , genetics
Resistance among Pseudomonas aeruginosa has risen dramatically and parallels the increase in fluoroquinolone (FQ) prescribing in recent years. Risk factors for FQ resistance in P. aeruginosa and its impact on outcomes need to be well characterized.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom